Treatment of refractory neurosarcoidosis with Infliximab

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 3, 2010, Pages 241-246

  Santos, Ernestina ^a   Shaunak, Sandip ^b   Renowden, Shelley ^c   Scolding, Neil J ^c  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b ROYAL PRESTON HOSPITAL   (United Kingdom)

^c FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CARBAMAZEPINE; DIPEPTIDYL CARBOXYPEPTIDASE; FOLIC ACID; GADOLINIUM; GLIMEPIRIDE; HYDROXYCHLOROQUINE; INFLIXIMAB; METFORMIN; METHOTREXATE; METHYLPREDNISOLONE; PHENYTOIN; PREDNISOLONE; PREDNISONE; STEROID;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIABETES MELLITUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARCOIDOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BRAIN; BRAIN DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; SARCOIDOSIS; SPINAL CORD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77649171185     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.149989     Document Type: Article

References (22)

1. Hoitsma E, Faber CG, Drent M, et al. Neurosarcoidosis: a clinical dilemma. Lancet Neurol 2004;3:397-407.
2. Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol 2004;17:311-16.
3. Heuser K, Kerty E. Neuro-ophthalmological findings in sarcoidosis. Acta Ophthalmol Scand 2004;82:723-9.
4. Joseph FG, Scolding NJ. Cerebral vasculitis: a practical approach. Pract Neurol 2002;2:80-93.
5. Sharma OP. Neurosarcoidosis. Chest 1991;100:301-2.
6. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosisddiagnosis and management. QJM 1999;92:103-17.
7. Scott TF, Yandora K, Valeri A, et al. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol 2007;64:691-6.
8. Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, et al. Treatment of therapy-resistant sarcoidosis with adalimumab. Clin Rheumatol 2006;25:596-7.
9. Haraoui B. Differentiating the efficacy of the tumor necrosis factor inhibitors. Semin Arthritis Rheum 2005;34(Suppl 1):7-11.
10. Kobylecki C, Shaunak S. Refractory neurosarcoidosis responsive to infliximab. Pract Neurol 2007;7:112-5.
11. Myatt N, Coghill G, Morrison K, et al. Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation. J Clin Pathol 1994;47:423-6.
12. White ES. Infliximab in sarcoidosis: more answers or more questions? Am J Respir Crit Care Med 2006;174:732-3.
13. Atzeni F, Sarzi-Puttini P, Doria A, et al. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review. Autoimmun Rev 2005;4:144-52.
14. Baughman RP, Drent M, Kavuru M, et al; Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006;174:795-802.
15. Ahmed MM, Mubashir E, Dossabhoy NR. Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab. Clin Rheumatol 2007;26:1346-9.
16. Uthman I, Touma Z, Khoury M. Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol 2007;26:2001-3.
17. Cruz BA, Reis DD, Araujo CA; Minas Gerais Vasculitis Study Group. Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab. Rheumatol Int 2007;27:1181-3.
18. Morcos Z. Refractory neurosarcoidosis responding to infliximab. Neurology 2003;60:1220-1.
19. Salama B, Gicquel JJ, Lenoble P, et al. Optic neuropathy in refractory neurosarcoidosis treated with TNF-alpha antagonist. Can J Ophthalmol 2006;41:766-8.
20. Kumar G, Kang CA, Giannini C. Neurosarcoidosis presenting as a cerebellar mass. J Gen Intern Med 2007;22:1373-6.
21. Toth C, Martin L, Morrish W, et al. Dramatic MRI improvement with refractory neurosarcoidosis treated with infliximab. Acta Neurol Scand 2007;116:259-62.
22. Sweiss NJ, Welsch MJ, Curran JJ, et al. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis. Arthritis Rheum 2005;53:788-91.